Managing Advanced EGFR-Mutant NSCLC: Expert and Patient Perspectives : Episode 13

Future Perspectives in EGFR-Mutant Advanced NSCLC

February 18, 2025

Opinion

Video

Panelists discuss novel agents and strategies being explored for the future treatment of advanced EGFR-mutant NSCLC, sharing optimism about emerging therapies that could significantly improve patient outcomes.

EP: 1.Overview of EGFR-Mutant Advanced NSCLC

EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians

EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC

EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey

EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC

EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC

EP: 9.Intricacies of EGFR-Mutated NSCLC Care From the Patient Perspective

EP: 10.Patient Perspectives on Managing Side Effects from Amivantamab

EP: 11.Comprehensive Supportive Care for EGFR-Mutant Advanced NSCLC

EP: 12.Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey

Now Viewing

EP: 13.Future Perspectives in EGFR-Mutant Advanced NSCLC

Video content above is prompted by the following:

Dr. Spira: At a high level, what novel agents and strategies are being explored that you are hopeful for in the future treatment of advanced EGFR-Mutant NSCLC?